Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients.

Published in: Cancer management and research (2020)

We suggest that PD-1 could be a predictive biomarker for OC patients and successful immunotherapy.

Keyphrases